Vir Biotechnology, Inc. reports

Location: San Francisco, CA
Fiscal year end: 31 December

Vir Biotechnology, Inc. has filed 771 SEC EDGAR filings since 29 Jun 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 476-500 of 771 matching filings.

Per page

25

Current page

20

4

FORM 4 SUBMISSION

Filing date: 31 Aug 2021
Reporting date: 30 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 Aug 2021
Reporting date: 25 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Aug 2021
Reporting date: 24 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Aug 2021
Reporting date: 23 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Aug 2021
Reporting date: 23 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Aug 2021
Reporting date: 19 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Aug 2021
Reporting date: 18 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2021
Reporting date: 10 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Aug 2021
Reporting date: 04 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-39083

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39083

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Aug 2021
Reporting date: 01 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jul 2021
Reporting date: 27 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Jul 2021
Reporting date: 21 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Jul 2021
Reporting date: 19 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jul 2021
Reporting date: 15 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jul 2021
Reporting date: 13 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-91177

ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#3)

Filing date: 12 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jul 2021
Reporting date: 07 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jul 2021
Reporting date: 01 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 06 Jul 2021
Reporting date: 01 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 06 Jul 2021
Reporting date: 01 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jun 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 29 Jun 2021
Reporting date: 25 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39083

8-K

Filing date: 28 Jun 2021
Reporting date: 21 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .